Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam B Blechman

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Journal of Drugs in Dermatology : JDD|June 20, 2017
Aggressive Skin Cancers Occurring in Patients Treated With the Janus Kinase Inhibitor RuxolitinibAdam B Blechman, Christine E Cabell, Christine H Weinberger, et al.
JAMA Dermatology|September 3, 2015
Effect of Quadrivalent Human Papillomavirus Vaccination on Oral Squamous Cell PapillomasNika Cyrus, Adam B Blechman, Matthew Leboeuf, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Journal of Drugs in Dermatology : JDD|June 20, 2017
Aggressive Skin Cancers Occurring in Patients Treated With the Janus Kinase Inhibitor RuxolitinibAdam B Blechman, Christine E Cabell, Christine H Weinberger, et al.
JAMA Dermatology|September 3, 2015
Effect of Quadrivalent Human Papillomavirus Vaccination on Oral Squamous Cell PapillomasNika Cyrus, Adam B Blechman, Matthew Leboeuf, et al.
Pageof 2